Advanced Epithelial Ovarian Cancer: Have We Really Improved Care for Patients Aged 70 Years and Older? A 20-year Registry-based Study.

Fiche publication

Date publication

mai 2025

Journal

Clinical oncology (Royal College of Radiologists (Great Britain))

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DABAKUYO-YONLI Sandrine , Dr MARILIER Sophie , Dr QUIPOURT Valérie , Dr BENGRINE-LEFEVRE Leila , Dr MAMGUEM KAMGA Ariane

Tous les auteurs :
Barben J, Mamguem Kamga A, Quipourt V, Marilier S, Niogret J, Bengrine-Lefevre L, Dabakuyo-Yonli TS

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40446384

Résumé

Advanced epithelial ovarian cancer (aEOC, International Federation of Gynecology and Obstetrics(FIGO) stages IIIC-IV) is the most frequently diagnosed and lethal form of ovarian cancer. The aim of this study was to evaluate net survival (NS) over time and the differences between younger (<70 years) and older (≥70 years) patients (OPs).